Dermatology
- DISEASE INDICATIONS: Atopic Dermatitis
- MANUFACTURER: Leo Pharma
- USAGE: Subcutaneous
- MEDICINE APPROVED BY:
- Food and Drug Administration (FDA)
Adbry is a prescription medication used to treat moderate to severe atopic dermatitis in adults by inhibiting the action of the Interleukin-13 protein. It is administered via subcutaneous injection every two weeks and is not recommended for use in children under 18. The recommended dosage is 150mg, and Adbry should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F).
$1,299.00
Select optionsThis product has multiple variants. The options may be chosen on the product page
